Skip to content

The Clinical Efficacy Observation of CO2-Laser-Moxibustion in Treating Endometriosis Related Chronic Pelvic Pain

The Clinical Efficacy Observation of CO2-Laser-Moxibustion in Treating Endometriosis Related Chronic Pelvic Pain

Status
Recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ITMCTR
Registry ID
ITMCTR1900002429
Enrollment
Unknown
Registered
2019-06-28
Start date
2019-07-01
Completion date
Unknown
Last updated
2023-02-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

endometriosis related chronic pelvic pain

Interventions

Sponsors

Pudong New Area TCM Hospital
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
20 Years to 50 Years

Inclusion criteria

Inclusion criteria: 1. Female patients aged between 20-50 years; 2. meet the diagnostic criteria for endometriosis recommended by the Chinese Medical Association Obstetrics and Gynecology Branch Guidelines (2015); 3. have no pelvic nodules or uterine adnexa mass, or have lesion with diameter=4cm; 3).have no fertility needs, no intention to use hormone therapy; 4. agree to use the analgesic or non-steroidal anti-inflammatory drug, such as pain control, only under the guidance of a specialist in obstetrics and gynecology and will not change the regimen without permission; 5. meet the criteria for the qi and blood stasis type, or cold and damp stagnation type, or qi and blood deficiency type, or liver and kidney deficiency; 6. Volunteer to participate in this topic and sign the informed consent form.

Exclusion criteria

Exclusion criteria: 1. have any test drug or hormonal drug therapy has been used in the past 30 days; 2. have the imaging examination or pathological examination which suggest other tumor or cancer; 3. pregnant or lactate woman; 4. have disease that might influence the participation and the completion of the study, such as myocardial infarction or stroke, congestive heart failure, severe chronic obstructive pulmonary disease, cancer, diabetes, severe systemic disease, and severe mental illness in the past 3 months,local skin scars; 5. have medical history of infection or herpes in the treatment area; history of photosensitive dermatitis; 6. have participation of any participants-blinded laser moxibustion trial or simultaneous participation of any other research during this trial period; 7. are not willing to be randomly assigned.

Design outcomes

Primary

MeasureTime frame
Gracely Box Scale;

Secondary

MeasureTime frame
records of application NSAIDs;visual analogue scale;

Countries

China

Contacts

Public ContactShen Xueyong

Pudong New Area TCM Hospital

pzyzjk@163.com+86 13564599607

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Feb 4, 2026